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Background: Hyperbaric oxygenation was shown to increase bone healing in a rabbit model. However, little is
known about the regulatory factors and molecular mechanism involved.We hypothesized that the effect of
hyperbaric oxygen (HBO) on bone formation is mediated via increases in the osteogenic differentiation of
mesenchymal stem cells (MSCs) which are regulated by Wnt signaling.
Methods: The phenotypic characterization of the MSCs was analyzed by flow cytometric analysis. To investigate the
effects of HBO on Wnt signaling and osteogenic differentiation of MSCs, mRNA and protein levels of Wnt3a, beta-catenin,
GSK-3beta, Runx 2, as well as alkaline phosphatase activity, calcium deposition, and the intensity of von Kossa staining
were analyzed after HBO treatment. To investigate the effects of HBO on Wnt processing and secretion, the expression of
Wntless and vacuolar ATPases were quantified after HBO treatment.
Results: Cells expressed MSC markers such as CD105, CD146, and STRO-1. The mRNA and protein levels of Wnt3a,
β-catenin, and Runx 2 were up-regulated, while GSK-3β was down-regulated after HBO treatment. Western blot analysis
showed an increased β-catenin translocation with a subsequent stimulation of the expression of target genes after HBO
treatment. The above observation was confirmed by small interfering (si)RNA treatment. HBO significantly increased
alkaline phosphatase activity, calcium deposition, and the intensity of von Kossa staining of osteogenically differentiated
MSCs. We further showed that HBO treatment increased the expression of Wntless, a retromer trafficking protein, and
vacuolar ATPases to stimulate Wnt processing and secretion, and the effect was confirmed by siRNA treatment.
Conclusions: HBO treatment increased osteogenic differentiation of MSCs via regulating Wnt processing, secretion,
and signaling.
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Hyperbaric oxygen (HBO) therapy is a safe noninvasive
modality that increases the oxygen tension of tissues and
microvasculature [1]. HBO increases the expression of
Wnt-3 protein in neural stem cells [2]. A previous study
suggested that Wnt signaling could stimulate bone heal-
ing [3]. We previously reported the beneficial effects of
HBO on bone lengthening in a rabbit model [4]. How-
ever, little is known about the effects of HBO on the* Correspondence: jkc508@mail.cgu.edu.tw
†Equal contributors
2Department of Physiology, College of medicine, Chang Gung University, 259
Wen-Hwa 1st Road, Kweishan, 333 Taoyuan, Taiwan
Full list of author information is available at the end of the article
© 2014 Lin et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.osteogenesis and Wnt signaling in mesenchymal stem
cells (MSCs).
Wnt proteins are secreted lipid-modified signaling mol-
ecules that influence animal development [5]. The target
cells for the Wnt proteins expressed by MSCs may be
either MSCs themselves or other cell types in the bone
marrow [6]. On target cells, secreted Wnt protein interacts
with the receptors Frizzled and LRP5/6 to activate the β-
catenin pathway [7]. Activation of the Frizzled receptor
complex results in the inhibition of a phosphorylation cas-
cade that stabilizes intracellular β-catenin levels. β-Catenin
is subsequently translocated into the nucleus to regulate
the Wnt target genes. In the absence of Wnt protein,
β-catenin is phosphorylated by glycogen synthase kinase–
3β (GSK-3β) and subsequently degraded by proteasomes.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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proliferation and differentiation of MSCs [8]. Runx2, a
member of the runt homology domain transcription fac-
tor family, is essential for osteoblast differentiation [9].
Canonical Wnt signaling promotes osteogenesis by dir-
ectly stimulating Runx2 gene expression and this regula-
tion can be antagonized by secreted frizzled-related
protein-1 (SFRP1) [10].
In Wnt producing cells, endosomal transport and acid-
ification are essential functions in Wnt processing and
secretion [11,12]. Wnt is synthesized and lipid modified
in the endoplasmic reticulum (ER). It is then transported
to the Golgi complex, where it binds to Wntless (Wls).
Wls supports the transport of Wnt from the trans-Golgi
network (TGN) to the cell surface in vesicles, from which
Wnt is then released. After Wnt is released, Wls is inter-
nalized through AP-2/clathrin-mediated endocytosis. The
retromer complex interacts with Wls and retrieves Wls
from endosomes back to TGN, thereby maintaining the
normal levels of Wls protein [11]. The core of the retro-
mer complex consists of the VPS35, VPS26, and VPS29
subunits [13]. In the absence of retromer activity, inter-
nalized Wls is likely to be sorted into lysosomes and
then degraded [14,15]. Wls becomes unstable in the
absence of retromer activity, and mutant retromer
inhibited Wnt signaling [14-16]. The overexpression of
retromer can significantly enhance levels of Wls in mam-
malian cells even in the absence of the Wnt ligand [16].
The mammalian ortholog of Wls is GPR177, a putative or-
phan G protein–coupled receptor (GPCR) [17]. GPR177
has been shown to regulate Wnt protein secretion in cells
[15,18].
Vacuolar acidification is required for Wnt signaling
[12,19]. Vacuolar ATPases (V-ATPases) are large multisu-
bunit complexes that are organized into 2 domains that
operate by a rotary mechanism. The V1 domain is located
on the cytoplasmic side of the membrane, and carries out
ATP hydrolysis. The V0 domain is a membrane-embedded
complex that is responsible for translocating protons from
the cytoplasm to the extracellular space [20]. V-ATPase-
driven proton pumping and organellar acidification are
essential for vesicular trafficking along both the exocyt-
otic and endocytotic pathways of eukaryotic cells. The
inhibition of V-ATPase results in accumulation of the
Wnt3a-Wls complex, inhibits the release of Wnt3a, and
inhibits Wnt/β-catenin signaling both in cultured human
cells and in vivo [19].
In the present study, we found that the beneficial ef-
fect of HBO on the osteogenesis of MSCs is regulated
via Wnt signaling pathway. Science endosomal transport
and acidification are essential functions in Wnt secre-
tion, we further showed that HBO treatment increased
the expression of GPR177, VPS35, and V-ATPases to
stimulate Wnt processing and secretion.Methods
The experimental protocol was performed in accordance
with the Declaration of Helsinki and approved by the
human subjects Institutional Review Board of the Chang
Gung Memorial Hospital. Written informed consent was
obtained from all patients. Demographic and clinical data
such as age, gender and surgery reason were collected.Patients and surgical procedures
MSCs were harvested from 12 patients (5 females and 7
males) who underwent iliac bone grafting for spine fusion.
The mean age was 58.3 years-old, where the age range
from 39 to 77 years old. The cells from each patient were
separately evaluated. The cells from 3 or 4 patient were
subjected to each treatment. During bone graft harvesting,
10 mL of bone marrow was aspirated and collected in a
sterile heparin-rinsed syringe.Isolation and cultivation of MSCs
Each marrow sample was washed with PBS. Up to 2 × 108
nucleated cells in 5 mL of PBS were loaded onto 25 mL of
Percoll cushion (Pharmacia Biotech). A density gradient
was used as the isolation procedure to eliminate unwanted
cell types. A small percentage of cells were isolated from
the density interface at 1.073 g/mL. The cells were re-
suspended and plated at 2 × 105 cells per T-75 flasks. The
cells were maintained in Dulbecco's Modified Eagle's
Medium-Low Glucose (DMEM-LG; Gibco, Grand Island,
NY) that containing 20% fetal bovine serum (FBS) and
antibiotics at 37°C in a humidified atmosphere of 5% CO2
and 95% air. After 7 d of primary culturing, the non-
adherent cells were removed by changing the medium.
The MSCs grew as symmetric colonies and were subcul-
tured at 10 to 14 d by treatment with 0.05% trypsin (Gibco)
and seeded into fresh flasks.Flow cytometric analysis of surface antigen expression
When confluent, the MSCs were passaged 1 in 3, and a
sample was analyzed for MSCs marker expression by
flow cytometry. The cells were washed in phosphatebuf-
fered saline (PBS), and then removed from the flask by
0.05% trypsin (Gibco). 1 × 105 cells were incubated with
each mouse monoclonal primary antibody at 4°C for
30 minutes. Mouse FITC–conjugated anti-CD105 anti-
body (1:100 dilution), mouse PE–conjugated anti-CD146
antibody (1:100 dilution), and mouse FITC–conjugated
anti-CD34 antibody (1:100 dilution) were purchased from
Beckton Dickinson (Oxford, UK). Mouse PE–conjugated
anti-STRO-1 antibody (1:50 dilution) was purchased from
Santa Cruz (CA, USA). After wash, the cells were resus-
pended in 500 μl wash buffer and analyzed on a BD flow
cytometer (Oxford, UK).
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The cells were cultured in 100 mm culture dishes (2 × 105
per dish) in complete medium (DMEM-LG contain-
ing 20% FBS and antibiotics) or in osteogenic induction
medium (DMEM-LG containing 20% FBS, antibiotics,
100 μM ascorbate-2 phosphate, 100 nM dexamethasone,
and 10 mM β-glycerophosphate). The cells were either
maintained in 5% CO2/95% air throughout the experi-
ment or were HBO treated by exposure to 100% O2 for
25 min and then to 5% CO2/95% air for 5 min at 2.5 ATA
(atmospheres absolute) in a hyperbaric chamber (Huxley
Corporation, Taipei, Taiwan) for 90 min every 36 h.
RNA preparation and real-time quantitative polymerase
chain reaction analysis
After culturing for 1, 4, and 7 d with or without HBO
treatment, total RNA was extracted using a Qiagen RT kit
(Qiagen, USA) according to the manufacturer’s instructions.
The RNA concentration was evaluated by A260/A280
measurement. To detect Wnt3a, GSK-3β, β-catenin, Runx2,
and GAPDH RNA transcripts, cDNA was analyzed on an
ABI PRISM 7900 sequence detection system using TaqMan
PCR Master Mix (Applied Biosystems, Foster City, CA).
The cycle threshold (Ct) values were obtained, and the
data were normalized to GAPDH expression by using the
ΔΔCt method to calculate the relative mRNA level of each
target gene.
Small interfering RNA transfection
On day 1, 2 × 105 MSCs were plated onto a 6-well tissue
culture plate in 2.5 mL of OPTI-MEM (Invitrogen,
Carlsbad, CA) medium without antibiotics and serum.
The cells were then transfected with human β-catenin
small interfering (si)RNA or scrambled siRNA (Stealth
RNAi, Invitrogen) using Lipofectamine RNAiMAX (Invitro-
gen) according to the manufacturer’s instructions. After 8 h
of transfection, the culture medium was changed to osteo-
genic medium with 10% FBS and the cells were exposed to
HBO treatment. On days 4 and 7, the cells were re-
transfected once and exposed to HBO. After an additional
24 h of culturing, the cells were harvested for analysis. The
silencing effect on β-catenin and downregulation of Runx 2
was detected by real-time PCR after the treatments.
Western blot analysis
After culturing for 7 d with or without HBO treatment,
the cells were washed with PBS and extracted using M-
PER mammalian protein extraction reagent (Thermo,
USA). The protein content was quantitated using a pro-
tein assay kit (Pierce Biotechnology, IL), separated by 7.5%
SDS-PAGE for Wnt3a, GSK-3β, β-catenin, Runx2, β-actin,
and α-tubulin, and transferred onto membranes using a
transfer unit (Bio-Rad, USA). After blocking with 10%
non-fat milk, the membranes were incubated overnightat 4°C with 1000-fold diluted rabbit antibodies against
Wnt3a, GSK-3β (Cell Signaling, MA, USA) or mouse anti-
bodies against β-catenin (Millipore), β-actin (Millipore),
and Runx2 (Millipore). After washing, the membranes
were further incubated for 2 h with 10000-fold goat anti-
mouse IgG (Calbiochem, USA) or goat anti-rabbit IgG
(Millipore) conjugated to horseradish peroxidase. The
membranes were then washed and rinsed with ECL detec-
tion reagents (Amersham Pharmacia Biotech, UK). The
band images were photographed using ECL Hyperfilm
(Amersham). The intensity of each stained was quantified
using an image-analysis system (Image-Pro plus 5.0, Media
Cybernetics, USA).
Preparation of cytosolic and nuclear fractions for
β-catenin detection
After culturing for 7 d with or without HBO treatment,
the cells were rinsed with ice cold PBS, treated with 0.05%
trypsin, and then collected by centrifugation at 800 g. NE-
PER nuclear and cytoplasmic extraction reagents (Thermo
science, USA) were used to isolate cytoplasmic and nuclear
extracts from the cells. The protein content was quanti-
tated using a protein assay kit (Pierce), and separated by
7.5% SDS-PAGE to detect β-catenin (Millipore) and TATA
binding protein (TBP; Abcam, Cambridge, UK). The silen-
cing effect on β-catenin and downregulation of Runx 2 was
detected by western blotting after the treatments.
Quantitative measurement of alkaline phosphatase activity
After culturing for 7, 14, and 21 d with or without HBO
treatment, the cultured cells were washed with ice cold
PBS. A 5-mL of alkaline phosphatase (ALP) substrate
buffer (50 mM glycine, 1 mM MgCl2, pH 10.5), contain-
ing soluble ALP substrate (2.5 mM p-nitrophenyl phos-
phate), was added at room temperature. Twenty minutes
after adding the substrate, 1 mL of the buffer was removed
from the culture and mixed with 1 mL of 1 N NaOH to
halt each reaction. The absorbance of each mixture was
determined on an ELISA plate-reader (MRX; Dynatech
Labs) at 405 nm. Enzyme activity was expressed as n mole
p-nitrophenol/min.
Calcium level quantification
After culturing for 7, 14, and 21 d with or without HBO
treatment, the cultured cells were rinsed with ice cold
PBS and placed into 5 mL of 0.5 N HCl. Calcium was
extracted from the cells by gently shaking the cultures
for 24 h. Cellular debris was centrifuged and the calcium
in the supernatant was measured using a Quantichrom
calcium assay kit (DICA-500, Bioassay systems, USA).
von Kossa staining
After culturing for 21 d with or without HBO treatment,
culture dishes were rinsed twice with 5 mL of Tyrode’s
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lin for 1 h. A 10-mL aliquot of freshly prepared 2% (w/v)
silver nitrate in water was added, and the dishes were
kept in dark for 30 min. The plates were then washed
thoroughly with distilled water and exposed to bright light
for 30 min. The presence of mineral deposits was indi-
cated by the development of a black precipitate on the
mineralized matrix. The matrix intensity was quantified
by image-analysis system (Image-Pro plus 5.0).
Dedicated Wnt secretion factors assay
After culturing for 1, 4, and 7 d with or without HBO
treatment, the culture medium was collected and the
cells were washed with ice cold PBS and cellular protein
was extracted using M-PER protein extraction reagent
(Thermo, USA). Each protein extraction was separated
by 7.5% SDS-PAGE to detect the GPR177 (Millipore),
VPS35 (Abcam), ATP6V0 (Abcam), Wnt3a (Millipore), and
β-actin (Millipore). The secreted Wnt3a in the collected
medium was quantified by ELISA (USCN Life Science,
Wuhan, PR China).
RNAi treatment for GPR177, VPS35, and V-ATPases
MSCs were transfected with siRNA for GPR177, VPS35,
and ATP6V0 (Santa Cruz), respectively on days 1, 4, and
7 by using the same protocol above described. Silencing
was detected by western blotting after the treatments.
The secreted Wnt3a in the collected medium was quan-
tified by ELISA (USCN).
Statistical analysis
Data are given as mean ± standard devision (SD) of the
results from three or four different samples in each item
of the experiment. The cells from each sample were sep-
arately evaluated. Differences between two groups were
measured by the Student’s t-test. A p value less than
0.05 was defined statistically significant difference.
Results
Flow cytometry analysis
Primary adherent human MSCs from 4 donors were cul-
tured in control medium, and cells were analyzed for ex-
pression of MSC markers using flow cytometry at passage
1. The percentage of cells expressing the MSC markers
CD146, CD105, and Stro-1 and hematopoietic cell marker
CD34 were shown in Figure 1. The mean percentages
of CD146+, CD105+, Stro-1+, and CD34+ cells in the cell
preparations from 4 patients (n = 4) were calculated to
be 28.2% ± 1.66%, 90.0% ± 1.94%, 32.3% ± 0.89%, and
0.10% ± 0.03%, respectively.
Effect of HBO on mRNA expression by MSCs
Real-time Q-PCR data showed that the mRNA ratios of
Wnt3a (II / I, 3.16 ± 0.72-fold on D7, **p < 0.01), β-catenin(II / I, 1.85 ± 0.1-fold on D7, *p < 0.05), and Runx2 (II / I,
1.81 ± 0.07-fold on D7, *p < 0.05) were up-regulated, while
GSK-3β (II / I, 0.55 ± 0.09-fold on D7, *p < 0.05) was
down-regulated after HBO treatment (Figure 2A). The
mRNA levels of β-catenin (II / I; 2.0 ± 0.22-fold, *p < 0.05,
Figure 2B), and Runx2 (II / I; 2.37 ± 0.44-fold, *p < 0.05,
Figure 2C) were up-regulated after HBO treatment.
The silencing effect on β-catenin (II / I vs. III / I, 2.0 ± 0.22-
fold vs. 0.39 ± 0.04-fold, **p < 0.01, Figure 2B) and downreg-
ulating effect for Runx2 (II / I vs. III / I, 2.37 ± 0.45-fold vs.
0.46 ± 0.07-fold, *p < 0.05, Figure 2C) by β-catenin siRNA
were detected after the treatments. No significant difference
was shown by scrambled siRNA treatment (II / I vs. IV / I,
2.0 ± 0.22-fold vs. 1.97 ± 0.24-fold, ***p > 0.05, Figure 2B;
II / I vs. IV / I, 2.37 ± 0.45-fold vs. 2.31 ± 0.46-fold, ***p >
0.05, Figure 2C) (I, induction; II, induction +HBO; III, in-
duction +HBO+ siRNA; IV, induction +HBO+ scram-
bled siRNA).
Effect of HBO on protein expression by MSCs
The Western blot data showed that the protein levels of
Wnt3a (1.63 ± 0.22-fold, p < 0.05), β-catenin (1.84 ± 0.11-
fold, p < 0.05) and Runx2 (1.63 ± 0.10-fold, p < 0.05) were
upregulated but GSK-3β (0.76 ± 0.05-fold, p < 0.05) was
downregulated after HBO treatment (Figure 3). HBO in-
creased the osteogenic differentiation of the MSCs and
the Wnt pathway signaling. We found that the β-catenin
protein levels in the nuclear fractions were up-regulated
after HBO treatment (2.91 ± 0.75-fold, p < 0.05, Figure 4A).
In addition, the Runx2 protein levels were up-regulated
after HBO treatment (2.32 ± 0.16-fold, p < 0.05, Figure 4B).
HBO treatment increased the translocation of β-catenin
from the cytosol into the nucleus. To explore whether the
effect of HBO on Runx2 expression was via transloca-
tion of β-catenin, the cells were transfected with siRNA
against β-catenin. We found that the increased β-catenin
(Figure 4A) and Runx2 (Figure 4B) protein levels by HBO
treatment were all down-regulated by β-catenin siRNA
treatment.
Long-term effects of HBO on MSCs
HBO significantly increased ALP activity after 7 d (33.7 ±
4.5 vs. 45.6 ± 6.5, *p < 0.05), 14 d (66.3 ± 5.1 vs. 90.2 ± 7.6,
**p < 0.01), and 21 d (53.2 ± 3.2 vs. 65.9 ± 5.1, **p < 0.01) of
culturing (Figure 5A). The ALP activity increased was co-
incided with the increase of calcium levels after 14 d
(149.1 ± 25.4 vs. 234.0 ± 26.7, *p < 0.05) and 21 d (331.0 ±
38.7 vs. 492.8 ± 48.4, **p < 0.01) of culturing (Figure 5B) in
the osteogenic induction medium. The deposition of a cal-
cified matrix on the surface of the culture dish was evident
by von Kossa staining. The matrix intensity for the induc-
tion +HBO group and induction group were 557505.3 ±
55457.4 and 382909.7 ± 55873.8 which were quantified by
image-analysis system. Greater positive staining through
Figure 2 Effect of HBO on mRNA expression by MSCs. The mRNA ratios of Wnt3a (A, II / I, **p < 0.01, n = 3, Student’s t-test), β-catenin (A, II / I,
*p < 0.05, n = 3, Student’s t-test), and Runx2 (A, II / I, *p < 0.05, n = 3, Student’s t-test) were up-regulated, while GSK-3β (A, II / I, *p < 0.05, n = 3,
Student’s t-test) was down-regulated after HBO treatment. The mRNA levels of β-catenin (B, II / I, *p < 0.05, n = 4, Student’s t-test) and Runx2 (C, II / I,
*p < 0.05, n = 4, Student’s t-test) were up-regulated after HBO treatment. The silencing effect on β-catenin (B, II vs. III, **p < 0.01, n = 4, Student’s t-test)
and downregulating effect for Runx2 (C, II vs. III, *p < 0.05, n = 4, Student’s t-test) by β-catenin siRNA were detected after the treatments. No significant
difference was shown between II and IV (***p > 0.05, n = 4, Student’s t-test, B, C). (I, induction; II, induction + HBO; III, Induction + HBO+ siRNA; IV,
Induction + HBO + scrambled siRNA).
Figure 1 Flow cytometry analysis of passage 1 cells from 1 patient. The percentage of cells expressing the MSC markers CD146, CD105, and
Stro-1 and hematopoietic cell marker CD34 were shown. The blue line areas represent the distribution of cells stained by the respective antibodies; the
red line areas are control cells without staining. Percentage numbers indicate the percentages of cells positively stained by the respective antibodies in
the flow cytometry analysis.
Lin et al. BMC Musculoskeletal Disorders 2014, 15:56 Page 5 of 10
http://www.biomedcentral.com/1471-2474/15/56
Figure 3 Effect of HBO on protein expression by MSCs. The western
blot data showed that the protein levels of Wnt3a (p < 0.05, n = 4,
Student’s t-test), β-catenin (p < 0.05, n = 4, Student’s t-test) and Runx2
(p < 0.05, n = 4, Student’s t-test) were upregulated but GSK-3β (p < 0.05,
n = 4, Student’s t-test) was downregulated after HBO treatment.
Figure 4 Effect of HBO on β-catenin translocation in MSCs. The protein
HBO treatment (2.91 ± 0.75-fold, p < 0.05, n = 3, Student’s t-test, A). No sign
treatment (1.04 ± 0.22-fold, p > 0.05, n = 3, Student’s t-test, A). The increased
all down-regulated by β-catenin siRNA treatment.
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group was observed compared to the induction group
(1.47 ± 0.23-fold, p < 0.05, Figure 5C).Effect of HBO on GPR177 and Wnt3a protein levels
Protein levels of GPR177 (Wls) were up-regulated after
HBO treatment (IH/I, 1.67 ± 0.05-fold, p < 0.01, n = 3,
Student’s t-test,) and the effect of HBO was reduced
after GPR177 siRNA treatment (IH/I vs. IH + siRNA/I;
1.67 ± 0.05-fold vs. 0.69 ± 0.07-fold, p < 0.01, n = 3, Student’s
t-test; Figure 6A). The Wnt3a levels in the cell lysates (IH/I,
1.89 ± 0.09-fold, p < 0.05, n = 3, Student’s t-test; Figure 6B)
and conditioned culture medium (I vs. IH; 97.7 ± 2.8 pg/mL
vs. 125.3 ± 7.2 pg/mL, *p < 0.05, n = 3, Student’s t-test;
Figure 6C) were both up-regulated after HBO treatment.
Interestingly, the effect of HBO on secreted (Figure 6C),
but not intracellular Wnt3a (Figure 6B), was reduced
by GPR177 siRNA treatment (IH/I vs. IH + siRNA/I;
1.89 ± 0.09-fold vs. 2.12 ± 0.14-fold, p > 0.05, n = 3, Student’s
t-test; Figure 6B), ( IH vs. IH + siRNA; 125.3 ± 7.2 pg/mL vs.
95.4 ± 2.5 pg/mL, *p < 0.05, n = 3, Student’s t-test; Figure 6C)
(I, induction; IH, induction +HBO).Effect of HBO on the expression of VPS35 and Wnt3a
Protein levels of VPS35 (retromer subunit) were up-
regulated after HBO treatment in the cell lysates (IH/I,
1.86 ± 0.11-fold, p < 0.01, n = 3, Student’s t-test) and the
effect of HBO was reduced through VPS35 siRNA treat-
ment (IH/I vs. IH + siRNA/I; 1.86 ± 0.11-fold vs. 1.22 ±
0.04-fold, p < 0.05, n = 3, Student’s t-test; Figure 7A). Thelevels of β-catenin in the nuclear fractions were up-regulated after
ificant difference in the cytoplasmic fractions was shown after HBO
protein levels of β-catenin (A) and Runx2 (B) by HBO treatment were
Figure 5 Long-term effects of HBO on MSCs. (A) HBO significantly increased alkaline phosphatase activity after 7 d (*p < 0.05, n = 4, Student’s
t-test), 14 d (**p < 0.01, n = 4, Student’s t-test), and 21 d (**p < 0.01, n = 4, Student’s t-test) of culturing. (B) HBO significantly increased calcium
levels after 14 d (*p < 0.05, n = 4, Student’s t-test) and 21 d (**p < 0.01, n = 4, Student’s t-test) of culturing. (C) Greater positive von Kossa staining
through the matrix at the surface layer of the HBO group was observed compared to the control group (1.473 ± 0.23-fold, p < 0.05, n = 3,
Student’s t-test).
Figure 6 Effect of HBO on the expression of GPR177 and
Wnt3a. Protein levels of GPR177 were up-regulated after HBO treatment
in the cell lysates (1.67 ± 0.05-fold, p < 0.01, A) and the effect of HBO was
reduced through GPR177 siRNA treatment (1.67 ± 0.05-fold vs. 0.69 ±
0.07-fold, p < 0.01, A). The amounts of Wnt3a in the cell lysates (1.89 ±
0.09-fold, p < 0.05, B) and conditioned culture medium (I vs. IH, *p < 0.05,
C) were both up-regulated after HBO treatment. However, the effect of
HBO on secreted Wnt3a was reduced (IH vs. IH + siRNA, *p < 0.05, C), but
the intracellular Wnt3a levels were not affected (IH/I vs. IH + siRNA/I,
p > 0.05, B) by GPR177 siRNA treatment. Each bar represents the value of
the mean ± SD and analyzed by Student t-test (I, induction;
IH, induction +HBO).
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p < 0.05, n = 3, Student’s t-test; Figure 7B) and conditioned
culture medium (I vs. IH; 89.2 ± 5.6 pg/mL vs. 117.1 ±
6.4 pg/mL, **p < 0.01, n = 3, Student’s t-test; Figure 7C)
were both up-regulated after HBO treatment. However,
the effect of HBO on secreted Wnt3a was reduced (IH vs.
IH + siRNA; 117.1 ± 6.4 pg/mL vs. 93.6 ± 4.2 pg/mL, **p <
0.01, n = 3, Student’s t-test; Figure 7C), but the intracellular
Wnt3a levels were not affected (IH/I vs. IH + siRNA/I;
1.46 ± 0.03-fold vs. 1.51 ± 0.04-fold, p > 0.05, n = 3, Student’s
t-test; Figure 7B) by VPS35 siRNA treatment. The possible
effects of VPS35 on GPR177 stability after HBO treatment
was examined, we found that GPR177 level was reduced
(0.46 ± 0.11-fold, p < 0.01, n = 3, Student’s t-test; Figure 7D)
when VPS35 was suppressed (0.38 ± 0.07-fold, p < 0.01,
n = 3, Student’s t-test; Figure 7D) by VPS35 siRNA
treatment.Effect of HBO on the expression of ATP6V0 and Wnt3a
Protein levels of ATP6V0 were up-regulated after HBO
treatment in the cell lysates (IH/I, 1.71 ± 0.12-fold, p < 0.01,
n = 3, Student’s t-test) and the effect of HBO was reduced
by ATP6V0 siRNA treatment (IH/I vs. IH + siRNA/I;
1.71 ± 0.12-fold vs. 0.72 ± 0.07-fold, p < 0.01, n = 3, Student’s
t-test; Figure 8A). The Wnt3a levels in the cell lysates (IH/I;
1.89 ± 0.07-fold, p < 0.01, n = 3, Student’s t-test; Figure 8B)
and conditioned culture medium (I vs. IH; 95.1 ± 6.6 pg/
mL vs. 118.4 ± 14.7 pg/mL, *p < 0.05, n = 3, Student’s t-test;
Figure 8C) were both up-regulated after HBO treatment.
However, the effect of HBO on Wnt3a levels was reduced
in the conditioned medium (IH vs. IH + siRNA; 118.4 ±
14.7 pg/mL vs. 92.3 ± 3.7 pg/mL, **p < 0.01, n = 3, Student’s
t-test; Figure 8C) but not in the cell lysates (IH/I vs. IH +
siRNA/I; 1.89 ± 0.07-fold vs.1.93 ± 0.05-fold, p > 0.05, n = 3,
Student’s t-test; Figure 8B) after ATP6V0 siRNA treatment.
Figure 7 Effect of HBO on the expression of VPS35 and Wnt3a.
Protein levels of VPS35 were up-regulated after HBO treatment in the
cell lysates (1.86 ± 0.11-fold, p < 0.01, A) and the effect of HBO was
reduced by VPS35 siRNA treatment (1.86 ± 0.11-fold vs. 1.22 ± 0.04-fold,
p < 0.05, A). The amounts of Wnt3a in the cell lysates (1.46 ± 0.03-fold,
p < 0.05, B) and conditioned culture medium (I vs. IH, **p < 0.01,
C) were both up-regulated after HBO treatment. The effect of HBO on
secreted Wnt3a was reduced (IH vs. IH + siRNA,**p < 0.01, C) but the
intracellular Wnt3a levels were not affected (IH/I vs. IH + siRNA/I, p > 0.05,
B) by VPS35 siRNA treatment. GPR177 level was reduced (0.46 ± 0.11-fold,
p < 0.01, D) when VPS35 was suppressed (0.38 ± 0.07-fold, p < 0.01, D) by
VPS35 siRNA treatment. Each bar represents the value of the mean ± SD
and analyzed by Student t-test (I, induction; IH, induction +HBO).
Figure 8 Effect of HBO on the expression of ATP6V0 and
Wnt3a. Protein levels of ATP6V0 were up-regulated after HBO
treatment in the cell lysates (1.71 ± 0.12-fold, p < 0.01, A) and the effect
of HBO was reduced by ATP6V0 siRNA treatment (1.71 ± 0.12-fold vs.
0.72 ± 0.07-fold, p < 0.01, A). The amounts of Wnt3a in the cell lysates
(1.89 ± 0.07-fold, p < 0.01, B) and conditioned culture medium (I vs. IH,
*p < 0.05, C) were both up-regulated after HBO treatment. The effect
of HBO on secreted Wnt3a was reduced (IH vs. IH + siRNA, **p < 0.01,
C) but the intracellular Wnt3a levels were not affected (IH/I vs. IH +
siRNA/I, p > 0.05, n = 3; B) by ATP6V0 siRNA treatment. Each bar
represents the value of the mean ± SD and analyzed by Student t-test
(I, induction; IH, induction + HBO).
Lin et al. BMC Musculoskeletal Disorders 2014, 15:56 Page 8 of 10
http://www.biomedcentral.com/1471-2474/15/56Discussion
Low oxygen tension was shown to promote the undiffer-
entiated state and attenuate differentiation capacity of
MSCs [21]. MSCs cultured under hypoxia exhibited de-
creased differentiation into osteogenic cells [22]. MSC
osteogenesis was associated with a higher level of oxygenconsumption compared with chondrogenesis, and there-
fore reduced oxygen consumption during the differenti-
ation process may inhibit osteogenesis [16]. Our present
findings supported those of previous studies, suggesting
that MSCs cultured under HBO undergo increased differ-
entiation into osteogenic cells by up-regulating Runx2 ex-
pression (Figure 1A). Because oxygen availability regulates
stem cells via Wnt/β-catenin signaling [23], we intended to
examine the molecular mechanisms involved after HBO
treatment by assessing the Wnt/β-catenin pathway. Our
data showed that the levels of Wnt3a, β-catenin, and Runx2
were upregulated, while GSK-3β was downregulated after
HBO treatment. HBO increased β-catenin mRNA pro-
duction to stimulate Runx2 mRNA expression and this
was confirmed by β-catenin siRNA treatment (Figure 2B,
2C). In addition, we found that the accumulated β-catenin
was subsequently translocated into the nucleus (Figure 4A)
where it upregulated Runx2 protein expression and the
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(Figure 4B).
Osteoblasts originate from MSC via a stepwise matur-
ation process. During the early stage of osteogenesis, the
cell cannot deposit calcium to form mineralized bone
[9]. In order to deposit calcium, the cells must enter the
late stage of osteogenesis [24]. Because we cannot find
the short-term effects of HBO (7 d) on calcium produc-
tion, we therefore, investigated the long-term effects of
HBO (14 and 21 d) on the osteogenesis of MSCs and found
that HBO significantly increased the expression of osteo-
genic markers (Figure 5A, B). Enhanced positive matrix
von Kossa staining at the surface layer of the HBO group
was seen compared to the control group (Figure 5C).
Three independent groups have identified the multi-pass
transmembrane protein Wls as a dedicate component re-
quired for Wnt secretion [25-27]. In the absence of Wls,
some Wnt proteins may sequestered in the secretory path-
way in Wnt-producing cells. The protein failed to reach
the plasma membrane and surrounding cells, thereby re-
sulting in Wnt loss-of-function phenotypes [14,25]. In the
present study, HBO treatment was found increase Wnt3a
production, however, Wnt3a was retained in the produ-
cing cells (Figure 6B) and was unable to move into cul-
ture medium (Figure 6C) during Wls (GPR177) siRNA
treatment. Clearly, the secretion of Wnt3a was impaired
upon knockdown of GPR177. GPR177 was shown to be
a transcriptional target of Wnt/β-catenin signaling in
embryonic axis formation [17], thus, Wnt-dependent
activation of GPR177 in the MSCs deserved further
investigation.
Parallel to the discovery of Wls, several researchers re-
vealed that retromer is also required for Wnt signaling.
Their observation suggested that in retromer mutant
clones, Wnt accumulates in Wnt-producing cells and
that the Wnt concentration gradient created by secretion
is strongly diminished [14,15,18]. However, one group
suggested that retromer (VPS35) siRNA in mammalian
cells impairs Wnt signaling but not Wnt secretion [28].
Although Wnt3a production was increased by HBO treat-
ment, our data were consistent with previous studies
which suggested that Wnt3a is retained in the producing
cells (Figure 7B) and is unable to secret into the culture
medium (Figure 7C) upon VPS35 siRNA treatment. Fur-
ther Wnt3a secretion was impaired upon the knockdown
of VPS35 [14,15,18]. In addition, internalized Wls is likely
to be sorted into lysosomes for degradation in the absence
of retromer [18]. In support of this view, our data showed
that the level of GPR177 was reduced when VPS35 was
suppressed by VPS35 siRNA treatment (Figure 7D). In
Wnt target cells, secreted Wnt protein interacts with the
receptors Frizzled and LRP5/6 to activate the β-catenin
pathway [7]. A previous study showed an indirect inter-
action between the LRP6 and VPS35 in HEK-293 cells[29], however, a possible interaction between the LRP6
and VPS35 in MSCs has not been reported.
V-ATPases regulate pH in acidic subcellular com-
partments including the Golgi complex and lysosomes.
Wls-dependent secretion of Wnt3a requires vacuolar
acidification [19]. In the presence of acidification inhibi-
tors, the Wnt3a-Wls complex is able to reach the cell sur-
face but the release of Wnt3a from Wls is hindered [19].
Treatment of cells with siRNA targeting two subunits of
V-ATPase (ATP6V1 and ATP6V0) inhibited Wnt signal-
ing [12]. Although we found that HBO treatment in-
creased Wnt3a production, the increased Wnt3a protein
was retained in the producing cells (Figure 8B) and was
unable to move into the culture medium (Figure 8C) dur-
ing ATP6V0 siRNA treatment.
Long-term and repeated HBO treatments may increase
oxidative stress; however, tolerance to HBO treatment
can be extended by intermittent exposure [30]. Because
exposure to HBO in clinical protocols is rather brief
(typically <2 h/d), studies show that antioxidant defenses
are adequate so that stresses related to increases in ROS
are reversible [30]. In addition, HBO treatment was shown
to suppress the apoptosis in degenerated disc cells [31] and
osteoarthritic chondrocytes [32], suggesting a beneficial ef-
fect of HBO. Taken together, our results suggested that
HBO increases osteogenic differentiation of MSCs via regu-
lation of Wnt processing, secretion, and signaling. Further
understanding of the regulatory factors and molecular
mechanism involved, HBO may serve as a therapeutic ap-
proach to increase bone healing in clinical setting.
Conclusions
HBO treatment increased osteogenic differentiation of
MSCs via regulating Wnt processing, secretion, and
signaling.
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